Cargando…

Microglial morphology in Alzheimer’s disease and after Aβ immunotherapy

Microglia are the brain immune cells and their function is highly dependent on cell motility. It was hypothesised that morphological variability leads to differences in motility, ultimately impacting on the microglial function. Here, we assessed microglial morphology in 32 controls, 44 Alzheimer’s d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Franco-Bocanegra, Diana K., Gourari, Yamina, McAuley, Ciaran, Chatelet, David S., Johnston, David A., Nicoll, James A. R., Boche, Delphine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342480/ https://www.ncbi.nlm.nih.gov/pubmed/34354209 http://dx.doi.org/10.1038/s41598-021-95535-0

Ejemplares similares

Molecular Mechanisms of Microglial Motility: Changes in Ageing and Alzheimer’s Disease
por: Franco-Bocanegra, Diana K., et al.
Publicado: (2019)

Microglial motility in Alzheimer’s disease and after Aβ42 immunotherapy: a human post-mortem study
por: Franco-Bocanegra, Diana K., et al.
Publicado: (2019)

Innate immunity in Alzheimer’s disease: the relevance of animal models?
por: Franco Bocanegra, Diana K., et al.
Publicado: (2017)

Microglial immunophenotype in dementia with Alzheimer’s pathology
por: Minett, Thais, et al.
Publicado: (2016)

The mitochondrial protein TSPO in Alzheimer’s disease: relation to the severity of AD pathology and the neuroinflammatory environment
por: Garland, Emma F., et al.
Publicado: (2023)

Aβ43 in human Alzheimer’s disease: effects of active Aβ42 immunization
por: Jäkel, Lieke, et al.
Publicado: (2019)

Investigating Interventions in Alzheimer's Disease with Computer Simulation Models
por: Proctor, Carole J., et al.
Publicado: (2013)

Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy
por: Zotova, Elina, et al.
Publicado: (2010)

Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer’s disease
por: Nicoll, James A R, et al.
Publicado: (2019)

Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease
por: Moro, Maria Luisa, et al.
Publicado: (2018)

Clinical impact of anti-inflammatory microglia and macrophage phenotypes at glioblastoma margins
por: Noorani, Imran, et al.
Publicado: (2023)

Testing a polygenic risk score for morphological microglial activation in Alzheimer’s disease and aging
por: Tio, Earvin S., et al.
Publicado: (2023)

Post-mortem analysis of neuroinflammatory changes in human Alzheimer’s disease
por: Gomez-Nicola, Diego, et al.
Publicado: (2015)

Metaflammasome components in the human brain: a role in dementia with Alzheimer's pathology?
por: Taga, Mariko, et al.
Publicado: (2016)

Immune environment of the brain in schizophrenia and during the psychotic episode: A human post-mortem study
por: De Picker, Livia J., et al.
Publicado: (2021)

Prospects and challenges of imaging neuroinflammation beyond TSPO in Alzheimer’s disease
por: Boche, Delphine, et al.
Publicado: (2019)

Systemic infection modifies the neuroinflammatory response in late stage Alzheimer’s disease
por: Rakic, Sonja, et al.
Publicado: (2018)

Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer’s disease
por: Asby, Daniel, et al.
Publicado: (2021)

An “Amyloid‐β Cleaner” for the Treatment of Alzheimer's Disease by Normalizing Microglial Dysfunction
por: Liu, Ruiyuan, et al.
Publicado: (2019)

Amyloid β Induces Lipid Droplet-Mediated Microglial Dysfunction in Alzheimer’s Disease
por: Prakash, Priya, et al.
Publicado: (2023)

The Locus Coeruleus in Aging and Alzheimer’s Disease: A Postmortem and Brain Imaging Review
por: Beardmore, Rebecca, et al.
Publicado: (2021)

Microglial Immunometabolism in Alzheimer’s Disease
por: Shippy, Daniel C., et al.
Publicado: (2020)

Accelerated microglial pathology is associated with Aβ plaques in mouse models of Alzheimer’s disease
por: Baron, Rona, et al.
Publicado: (2014)

Cu(II) enhances the effect of Alzheimer’s amyloid-β peptide on microglial activation
por: Yu, Fengxiang, et al.
Publicado: (2015)

Cromolyn Reduces Levels of the Alzheimer’s Disease-Associated Amyloid β-Protein by Promoting Microglial Phagocytosis
por: Zhang, Can, et al.
Publicado: (2018)

TREM2 expression in the human brain: a marker of monocyte recruitment?
por: Fahrenhold, Marie, et al.
Publicado: (2017)

Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models
por: Sebastian Monasor, Laura, et al.
Publicado: (2020)

Microglial phagocytosis induced by fibrillar β-amyloid is attenuated by oligomeric β-amyloid: implications for Alzheimer's disease
por: Pan, Xiao-dong, et al.
Publicado: (2011)

Biomarkers for Microglial Activation in Alzheimer's Disease
por: Lautner, Ronald, et al.
Publicado: (2011)

Histopathological correlates of haemorrhagic lesions on ex vivo magnetic resonance imaging in immunized Alzheimer’s disease cases
por: Scherlek, Ashley A., et al.
Publicado: (2022)

Clinical PET Imaging of Microglial Activation: Implications for Microglial Therapeutics in Alzheimer’s Disease
por: Shen, Zhiwei, et al.
Publicado: (2018)

Inflammatory process in Alzheimer's Disease
por: Meraz-Ríos, Marco A., et al.
Publicado: (2013)

The microglial immunoreceptor tyrosine‐based motif‐Syk signaling pathway is a promising target of immunotherapy for Alzheimer's disease
por: Wang, Shoutang, et al.
Publicado: (2023)

Genetics ignite focus on microglial inflammation in Alzheimer’s disease
por: Malik, Manasi, et al.
Publicado: (2015)

Immunotherapy for the treatment of Alzheimer’s disease: amyloid-β or tau, which is the right target?
por: Castillo-Carranza, Diana L, et al.
Publicado: (2013)

Quantitating the subtleties of microglial morphology with fractal analysis
por: Karperien, Audrey, et al.
Publicado: (2013)

The association between laminin and microglial morphology in vitro
por: Tam, Wing Yip, et al.
Publicado: (2016)

Early Onset Alzheimer's Disease and Oxidative Stress
por: Meraz-Ríos, Marco Antonio, et al.
Publicado: (2014)

Oxidative Stress and Metabolic Syndrome: Cause or Consequence of Alzheimer's Disease?
por: Luque-Contreras, Diana, et al.
Publicado: (2014)

CARD9 attenuates Aβ pathology and modifies microglial responses in an Alzheimer’s disease mouse model
por: Ennerfelt, Hannah, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1ilekada14972p58c2corjr699